321 related articles for article (PubMed ID: 36159867)
1. Bacterial outer membrane vesicles as a candidate tumor vaccine platform.
Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H
Front Immunol; 2022; 13():987419. PubMed ID: 36159867
[TBL] [Abstract][Full Text] [Related]
2. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
[TBL] [Abstract][Full Text] [Related]
3. Bacterial outer membrane vesicle-based cancer nanovaccines.
Gao X; Feng Q; Wang J; Zhao X
Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
Lei EK; Azmat A; Henry KA; Hussack G
Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
[TBL] [Abstract][Full Text] [Related]
5. OMV Vaccines and the Role of TLR Agonists in Immune Response.
Mancini F; Rossi O; Necchi F; Micoli F
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Outer Membrane Vesicles: From Discovery to Applications.
Sartorio MG; Pardue EJ; Feldman MF; Haurat MF
Annu Rev Microbiol; 2021 Oct; 75():609-630. PubMed ID: 34351789
[TBL] [Abstract][Full Text] [Related]
7. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.
Zheng K; Feng Y; Li L; Kong F; Gao J; Kong X
Theranostics; 2024; 14(2):761-787. PubMed ID: 38169585
[TBL] [Abstract][Full Text] [Related]
8. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
10. Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application.
Li D; Zhu L; Wang Y; Zhou X; Li Y
Biomed Pharmacother; 2023 Sep; 165():115120. PubMed ID: 37442066
[TBL] [Abstract][Full Text] [Related]
11. Metal-polyphenol "prison" attenuated bacterial outer membrane vesicle for chemodynamics promoted in situ tumor vaccines.
Nie W; Jiang A; Ou X; Zhou J; Li Z; Liang C; Huang LL; Wu G; Xie HY
Biomaterials; 2024 Jan; 304():122396. PubMed ID: 38043464
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
[TBL] [Abstract][Full Text] [Related]
13. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
Huang W; Meng L; Chen Y; Dong Z; Peng Q
Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
[TBL] [Abstract][Full Text] [Related]
15. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
[TBL] [Abstract][Full Text] [Related]
16. Bioengineering bacterial outer membrane vesicles as vaccine platform.
Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
[TBL] [Abstract][Full Text] [Related]
17. Bacterial Outer Membrane Vesicles as a Delivery System for Virulence Regulation.
Yoon H
J Microbiol Biotechnol; 2016 Aug; 26(8):1343-7. PubMed ID: 27221110
[TBL] [Abstract][Full Text] [Related]
18. Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The
König E; Gagliardi A; Riedmiller I; Andretta C; Tomasi M; Irene C; Frattini L; Zanella I; Berti F; Grandi A; Caproni E; Fantappiè L; Grandi G
Front Immunol; 2021; 12():752168. PubMed ID: 34819933
[TBL] [Abstract][Full Text] [Related]
19. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
[TBL] [Abstract][Full Text] [Related]
20. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
